In the rapidly evolving field of synthetic glycobiology, the development of a robust and efficient microbial or mammalian chassis is the cornerstone of successful bioproduction. However, simply inserting a biosynthetic pathway is rarely sufficient; the intricate regulatory networks of the host cell must be aligned with the metabolic demands of glycan or glycoprotein synthesis. CD BioGlyco offers a premier chip sequencing-based chassis validation service, providing researchers with an unprecedented look into the "control room" of their engineered strains.
Chromatin immunoprecipitation sequencing (ChIP-seq) has emerged as the gold standard for mapping protein-DNA interactions on a genome-wide scale. By employing this technology within our chassis strain validation service, we enable clients to confirm whether their synthetic transcription factors (TFs) are binding to the intended promoters, identify off-target effects that could lead to metabolic drain, and ensure that the host's native regulatory machinery is not interfering with the heterologous pathway.
Key Technologies
High-Resolution ChIP
Our proprietary ChIP protocol is optimized for a diverse range of glycobiology-relevant chassis. We utilize high-affinity, validated antibodies or specialized epitope tagging strategies to capture protein-DNA complexes with exceptional specificity. This ensures that even low-abundance transcription factors or transient regulatory interactions are captured during the validation process.
Next-Generation Sequencing (NGS)
Following the recovery of target-bound DNA fragments, we utilize state-of-the-art NGS platforms to generate millions of high-quality reads. Our "Deep-Map" approach provides the sensitivity required to detect subtle shifts in regulatory landscapes, allowing for the identification of binding sites with single-nucleotide resolution.
Bioinformatic Regulatory Network Reconstruction
Our bioinformatics suite goes beyond simple peak calling. We integrate ChIP-seq data with RNA-seq and metabolic flux analysis to provide a holistic view of the chassis's regulatory network. This allows us to predict how binding events translate into actual glycan yields and strain stability.
Engineering Reliability: Precision Mapping for Optimized Glyco-Chassis
At CD BioGlyco, our chip sequencing-based chassis validation service is a critical component of the broader chassis development framework. This service is specifically designed to bridge the gap between initial genetic design and large-scale fermentation. While many development projects focus solely on "writing" DNA, our validation service focuses on "reading" the functional state of the engineered cell to ensure the design is executed as intended.
The scope of this service covers the validation of both native and synthetic regulatory elements within a variety of chassis strains. In synthetic glycobiology, the production of complex molecules like human milk oligosaccharides (HMOs) or site-specific glycoproteins often requires the delicate balance of multiple enzymatic steps. Our service validates that the transcriptional regulators governing these steps are operating within their optimal parameters. We provide:
Transcription Factor Mapping: Confirmation of intended binding at synthetic promoter sites.
Off-Target Binding Assessment: Identification of unintended interactions that might lead to growth defects or metabolic bottlenecks.
Epigenetic Profiling: Analysis of histone modifications (in eukaryotic chassis like Pichia pastoris or CHO) that may silence glycoengineering cassettes.
Regulatory Network Stress Testing: Validation of how the chassis responds to different industrial fermentation conditions at the DNA-binding level.
By implementing these advanced methodologies, we help clients troubleshoot "low-yield" phenotypes that are often invisible to standard genomic or proteomic screens. Our validation provides the empirical evidence needed to move from a laboratory prototype to a commercially viable production strain with confidence.
Workflow
Chassis Culture and In Vivo Cross-linking
We begin by cultivating your engineered chassis under specific experimental conditions. To capture the dynamic interactions between proteins and DNA, we perform in vivo cross-linking using formaldehyde, "freezing" the regulatory state of the cell.
Cell Lysis and Chromatin Fragmentation
Cells are harvested and lysed to release the chromatin. We utilize precision ultrasonication or enzymatic digestion (MNase) to shear the DNA into optimal fragment sizes (typically 200-500 bp), ensuring high spatial resolution for the subsequent mapping.
Targeted Immunoprecipitation (IP)
The fragmented chromatin is incubated with highly specific antibodies targeted at the protein of interest. Using magnetic bead-based separation, we selectively enrich the DNA fragments that were bound to the regulatory proteins, while washing away non-specific background material.
Cross-link Reversal and DNA Purification
After the IP step, the protein-DNA cross-links are reversed through heat treatment and proteinase K digestion. The resulting DNA is purified and quantified, providing a library of sequences that represent the protein's "footprint" across the genome.
Library Preparation and High-Throughput Sequencing
The purified DNA is converted into a sequencing-ready library through adapter ligation and polymerase chain reaction (PCR) amplification. We then perform ultra-deep sequencing on our NGS platforms, generating the raw data required for comprehensive mapping.
Advanced Bioinformatic Analysis and Reporting
Our experts perform peak calling, motif discovery, and functional annotation. We provide a detailed report that includes binding site locations, regulatory network maps, and actionable recommendations for further chassis optimization.
Applications
Therapeutic Glycoprotein Production
Validating the regulatory stability of CHO or human cell lines engineered for the production of monoclonal antibodies (mAbs) or erythropoietin, ensuring consistent N-glycosylation patterns across batches.
HMO Biosynthesis in Microorganisms
Mapping the binding of synthetic regulators in E. coli or B. subtilis to optimize the flux of sugar nucleotides toward complex HMO structures.
Industrial Enzyme Secretion
Ensuring that fungal chassis like Aspergillus niger maintain high transcriptional activity of secretion-related genes, preventing the "unfolded protein response" (UPR) during high-titer production runs.
Plant-based Glycoengineering
Validating the integration and regulation of glycan-remodeling enzymes in plant chassis (e.g., Nicotiana benthamiana) to produce "humanized" plant-made pharmaceuticals with reduced immunogenicity.
Advantages
Unrivaled Sensitivity
Our optimized protocols allow for the detection of low-occupancy binding sites, providing a more complete picture than standard validation methods.
Host Compatibility
We have established validated ChIP-seq pipelines for bacteria, yeast, fungi, plants, and mammalian cells, making us a versatile partner for any glycobiology project.
Expert Bioinformatic Support
Our team doesn't just deliver raw data; we provide biological interpretation, linking protein-DNA interactions directly to glycan production phenotypes.
Integrated Multi-Omics Approach
We seamlessly combine ChIP-seq with RNA-seq and proteomics to provide a 360-degree view of your chassis's performance.
Frequently Asked Questions
Customer Review
"The ChIP-seq validation provided by CD BioGlyco was a game-changer for our HMO project. We were able to identify a specific off-target binding event that was suppressing our yield. After a quick redesign based on their data, our production increased by 40%."
– Z.F., Senior Scientist
"Their expertise in fungal chassis is unmatched. Validating the regulatory network of our Pichia strain allowed us to understand why our secretion levels were inconsistent. The reporting was clear, professional, and highly actionable."
– Q.W., Director of R&D
"Working with CD BioGlyco was a seamless experience. Their team handled everything from the complex cross-linking to the final network reconstruction. The resolution of the data was far superior to anything we had achieved in-house."
The chip sequencing-based chassis validation service at CD BioGlyco provides the critical biological insights necessary to transform a theoretical genetic design into a high-performing production chassis. By mapping the intricate protein-DNA interactions within your engineered strains, we help you eliminate bottlenecks, reduce off-target effects, and maximize glycan yields. Please feel free to contact us for more information and to discuss your project.
For research use only. Not intended for any clinical use.
